Clinical trial
Using Drug Augmentation to Treat Obsessive Compulsive Disorder Patients Who Did…
NCT00466609 · University of Sao Paulo, Other · Completed
Key facts
| NCT number | NCT00466609 |
|---|---|
| Title | Using Drug Augmentation to Treat Obsessive Compulsive Disorder Patients Who Did Not Respond to Previous Treatment |
| Official title | Pharmacological Augmentation Strategies for Obsessive Compulsive Disorder Patients Non-respondent to First Line Medication Treatment: a Double Blind Placebo Controlled Study |
| Acronym | EPMTOC |
| Lead sponsor | University of Sao Paulo, Other |
| Collaborators | Fundação de Amparo à Pesquisa do Estado de São Paulo Conselho Nacional de Desenvolvimento Científico e Tecnológico Novartis Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Obsessive Compulsive Disorder |
| Intervention type | Drug |
| Interventions | Clomipramine (fluoxetine plus clomipramine), Quetiapine (fluoxetine plus quetiapine), Placebo (fluoxetine plus placebo) |
| Enrollment | 54 |
| Start date | May 1, 2007 |
| Primary completion | Mar 1, 2010 |
| Completion | Apr 1, 2010 |
| First posted | Apr 27, 2007 |
| Last update posted | Oct 30, 2017 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: